These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1640866)

  • 1. Differences in metabolism of time-release and unmodified nicotinic acid: explanation of the differences in hypolipidemic action?
    Stern RH; Freeman D; Spence JD
    Metabolism; 1992 Aug; 41(8):879-81. PubMed ID: 1640866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in man.
    Figge HL; Figge J; Souney PF; Sacks FM; Shargel L; Janosik JE; Kaul AF
    J Clin Pharmacol; 1988 Dec; 28(12):1136-40. PubMed ID: 3243933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niacin catabolism in rodents.
    Shibata K; Kakehi H; Matsuo H
    J Nutr Sci Vitaminol (Tokyo); 1990 Apr; 36(2):87-98. PubMed ID: 2143779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet.
    Menon R; Tolbert D; Cefali E
    Biopharm Drug Dispos; 2007 Sep; 28(6):297-306. PubMed ID: 17571283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Excretion of Niacin Metabolites in Humans After Coffee Consumption.
    Kremer JI; Gömpel K; Bakuradze T; Eisenbrand G; Richling E
    Mol Nutr Food Res; 2018 Apr; 62(7):e1700735. PubMed ID: 29468817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites.
    Menon RM; González MA; Adams MH; Tolbert DS; Leu JH; Cefali EA
    J Clin Pharmacol; 2007 Jun; 47(6):681-8. PubMed ID: 17463214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bioavailability of sustained release nicotinic acid formulations.
    Neuvonen PJ; Roivas L; Laine K; Sundholm O
    Br J Clin Pharmacol; 1991 Oct; 32(4):473-6. PubMed ID: 1958442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of excess nicotinamide and nicotinic acid differs in rats.
    Shibata K
    J Nutr; 1989 Jun; 119(6):892-5. PubMed ID: 2526205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological doses of nicotinic acid and nicotinamide are independently metabolized in rats.
    Shibata K; Fukuwatari T; Suzuki C
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(2):86-93. PubMed ID: 24975217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.
    Menon RM; Adams MH; González MA; Tolbert DS; Leu JH; Cefali EA
    Int J Clin Pharmacol Ther; 2007 Aug; 45(8):448-54. PubMed ID: 17725178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of excess nicotinamide administration on the urinary excretion of nicotinamide N-oxide and nicotinuric acid by rats.
    Fukuwatari T; Wada H; Sasaki R; Shibata K
    Biosci Biotechnol Biochem; 2004 Jan; 68(1):44-50. PubMed ID: 14745162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid-chromatographic determination of free nicotinic acid and its metabolite, nicotinuric acid, in plasma and urine.
    Hengen N; Seiberth V; Hengen M
    Clin Chem; 1978 Oct; 24(10):1740-3. PubMed ID: 699281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers.
    Kesisoglou F; Rossenu S; Farrell C; Van Den Heuvel M; Prohn M; Fitzpatrick S; De Kam PJ; Vargo R
    J Pharm Sci; 2014 Nov; 103(11):3713-3723. PubMed ID: 25256703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The excretion of N1-methyl-2-pyridone-5-carboxylic acid and related compounds in human subjects after oral administration of nicotinic acid, trigonelline and N1-methyl-2-pyridone-5-carboxylic acid.
    Yuyama S; Suzuki T
    Adv Exp Med Biol; 1991; 294():475-9. PubMed ID: 1837687
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous quantification of niacin and its three main metabolites in human plasma by LC-MS/MS.
    Liu M; Zhang D; Wang X; Zhang L; Han J; Yang M; Xiao X; Zhang Y; Liu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Sep; 904():107-14. PubMed ID: 22884475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolism of high intakes of tryptophan, nicotinamide and nicotinic acid in the rat.
    McCreanor GM; Bender DA
    Br J Nutr; 1986 Nov; 56(3):577-86. PubMed ID: 2960374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral and biological changes induced in nicotinic acid and related compounds by ultraviolet light.
    Abelson D; Parthé E; Lee KW; Boyle A
    Biochem J; 1965 Sep; 96(3):840-52. PubMed ID: 4285897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic toxicity of unmodified and time-release preparations of niacin.
    Rader JI; Calvert RJ; Hathcock JN
    Am J Med; 1992 Jan; 92(1):77-81. PubMed ID: 1731514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolism of nicotinamide coenzymes following total-body irradiation. I. Catabolism of NAD and excretion of its metabolites].
    Gerber GB; Deroo J
    Strahlentherapie; 1969 Jun; 137(6):724-9. PubMed ID: 4311217
    [No Abstract]   [Full Text] [Related]  

  • 20. [URINARY EXCRETION OF N1-METHYLINICOTINAMIDE, N1-METHYL-2-PYRIDONE-5-CARBOXAMIDE AND OF KOENIG-POSITIVE SUBSTANCE IN SCHOOL-AGE CHILDREN].
    MAINARDI L; SACCHETTI G; TENCONI LT
    Acta Vitaminol; 1963; 17():153-6. PubMed ID: 14092054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.